Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P200039/S025

SHOCKWAVE INTRAVASCULAR LITHOTRIPSY (IVL) SYSTEM WITH SHOCKWAVE C2/C2+ CORONARY IVL CATHETER

Shockwave Medical, Inc. · Decision date Sep 11, 2026

MEDTECHLEDGER EXPLANATIONP200039/S025

What did the FDA decide?

The FDA record for P200039/S025 describes a 30-day notice submitted by Shockwave Medical, Inc. for the Shockwave intravascular lithotripsy system with the Shockwave C2/C2+ coronary IVL catheter. The stated change is a raw material impurity profile change in the hydrophilic coating at a supplier, listed under the reason process change involving a manufacturer, sterilizer, packager or supplier.

The identifier places S025 as a supplement to PMA P200039, so the notice concerns that previously cleared system rather than a new approval of the whole device. The record states only the reported purpose of the supplier coating-material change; it does not document safety or clinical effectiveness, and the notice does not specify which material, impurity, limit or test method is involved, nor the supplier's identity.

FDA approval order statement

a raw material impurity profile change (for the hydrophilic coating) at a supplier
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Sep 11, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P200039/S025
Regulatory pathway
PMA supplement
Product code
QMG
Decision code
OK30
Decision date
Sep 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Shockwave intravascular lithotripsy system.

Product code
QMG
FDA device class
3

For the original device and its historical approval scope, see PMA P200039. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P200039 · Original PMA

    Shockwave Intravascular Lithotripsy (IVL) System with Shockwave C2 Coronary Intravascular Lithotripsy (IVL) Catheter

  2. P200039/S025 received

    Application receipt date recorded by FDA.

  3. P200039/S025 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P200039. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200039

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Shockwave Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
5403 Betsy Ross Dr., Santa Clara, CA, 95054

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records